ES2173910T3 - Anticuerpos humanizados dirigidos contra el antigeno a33. - Google Patents

Anticuerpos humanizados dirigidos contra el antigeno a33.

Info

Publication number
ES2173910T3
ES2173910T3 ES94902059T ES94902059T ES2173910T3 ES 2173910 T3 ES2173910 T3 ES 2173910T3 ES 94902059 T ES94902059 T ES 94902059T ES 94902059 T ES94902059 T ES 94902059T ES 2173910 T3 ES2173910 T3 ES 2173910T3
Authority
ES
Spain
Prior art keywords
directed against
humanized antibodies
antibodies directed
against antigen
humanized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94902059T
Other languages
English (en)
Inventor
David John King
John Robert Adair
Raymond John Owens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celltech R&D Ltd
Original Assignee
Celltech Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929225853A external-priority patent/GB9225853D0/en
Priority claimed from GB939315249A external-priority patent/GB9315249D0/en
Application filed by Celltech Therapeutics Ltd filed Critical Celltech Therapeutics Ltd
Application granted granted Critical
Publication of ES2173910T3 publication Critical patent/ES2173910T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

SE DESCRIBEN PROTEINAS DE UNION DEL ANTIGENO A33 PARA SU USO EN LA DIAGNOSIS O EL TRATAMIENTO DE TUMORES COLORRECTALES Y METASTASIS QUE SE DERIVAN DE LOS MISMOS. LA PROTEINA DE UNION PUEDE SER UN ANTICUERPO A33 HUMANIZADO, QUE INCLUYA MOLECULAS DE ANTICUERPO COMPLETAS, FRAGMENTOS DE LAS MISMAS, Y, ESPECIALMENTE, PROTEINAS MONOESPECIFICAS, MULTIVALENTES QUE COMPRENDAN DOS, TRES, CUATRO O MAS ANTICUERPOS O FRAGMENTOS DE LOS MISMOS UNIDOS ENTRE SI MEDIANTE UN AGENTE ENLAZADOR. PARA DIAGNOSIS O TERAPIAS EL ANTICUERPO A33 HUMANIZADO PUEDE UNIRSE A UNA MOLECULA PORTADORA.
ES94902059T 1992-12-10 1993-12-10 Anticuerpos humanizados dirigidos contra el antigeno a33. Expired - Lifetime ES2173910T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929225853A GB9225853D0 (en) 1992-12-10 1992-12-10 Antigen-binding proteins
GB939315249A GB9315249D0 (en) 1993-07-22 1993-07-22 Antigen-binding proteins

Publications (1)

Publication Number Publication Date
ES2173910T3 true ES2173910T3 (es) 2002-11-01

Family

ID=26302139

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94902059T Expired - Lifetime ES2173910T3 (es) 1992-12-10 1993-12-10 Anticuerpos humanizados dirigidos contra el antigeno a33.

Country Status (12)

Country Link
EP (1) EP0628077B1 (es)
JP (1) JPH07504334A (es)
AT (1) ATE214734T1 (es)
AU (1) AU675268B2 (es)
CA (1) CA2128544A1 (es)
DE (1) DE69331735T2 (es)
DK (1) DK0628077T3 (es)
ES (1) ES2173910T3 (es)
GB (1) GB2278357B (es)
NZ (1) NZ258618A (es)
PT (1) PT628077E (es)
WO (1) WO1994013805A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190640B1 (en) * 1985-04-19 2001-02-20 Ludwig Institute For Cancer Research Method for treating neoplasia using humanized antibodies which bind to antigen A33
US5851526A (en) * 1985-04-19 1998-12-22 Ludwig Institute For Cancer Research Methods of treating colon cancer utilizing tumor-specific antibodies
GB9215541D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
GB9215540D0 (en) * 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US6307026B1 (en) * 1992-12-10 2001-10-23 Celltech Limited Humanized antibodies directed against A33 antigen
CA2126819A1 (en) * 1993-07-09 1995-01-10 Richard P. Mccabe Kit and method for pretargeting
GB9424449D0 (en) * 1994-12-02 1995-01-18 Wellcome Found Antibodies
US5712374A (en) * 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
US5712369A (en) * 1995-08-24 1998-01-27 Ludwig Institute For Cancer Research Isolated protein which binds to A33 antibody, and peptides corresponding to portions of the protein
AU6537798A (en) * 1997-03-14 1998-10-12 Denise Casentini-Borocz Targeted cytolysis of cancer cells
DK1283214T3 (da) 2000-04-21 2007-06-11 Fuso Pharmaceutical Ind Hidtil ukendte kollektiner
IL161418A0 (en) * 2001-10-15 2004-09-27 Immunomedics Inc Direct targeting binding proteins
US7579187B2 (en) * 2004-09-06 2009-08-25 Kyoma Hakko Kirin Co., Ltd. Anti-A33 antibody
US8901281B2 (en) 2005-06-17 2014-12-02 Merck Sharp & Dohme Corp. ILT3 binding molecules and uses therefor
AU2007345745C1 (en) 2006-06-19 2013-05-23 Merck Sharp & Dohme Corp. ILT3 binding molecules and uses therefor
US11733235B2 (en) 2016-12-27 2023-08-22 Chugai Seiyaku Kabushiki Kaisha Method for evaluating immunogenicity of test substance
US11555072B2 (en) * 2017-09-23 2023-01-17 Memorial Sloan Kettering Cancer Center A33 antibody compositions and methods of using the same in radioimmunotherapy
CN110540591A (zh) * 2019-08-09 2019-12-06 无锡傲锐东源生物科技有限公司 一种抗糖蛋白A33（Glycoprotein A33）单克隆抗体及其免疫检测应用
CN116200428A (zh) * 2022-12-20 2023-06-02 上海碧博生物医药工程有限公司 一种pBG质粒载体及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091542A (en) * 1990-03-09 1992-02-25 Hybritech Incorporated Tris-maleimido compounds as intermediates in trifunctional antibody synthesis
GB9012995D0 (en) * 1990-06-11 1990-08-01 Celltech Ltd Multivalent antigen-binding proteins
GB9014932D0 (en) * 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
GB9112536D0 (en) * 1991-06-11 1991-07-31 Celltech Ltd Chemical compounds

Also Published As

Publication number Publication date
NZ258618A (en) 1997-02-24
EP0628077A1 (en) 1994-12-14
DE69331735T2 (de) 2002-09-26
DK0628077T3 (da) 2002-07-01
CA2128544A1 (en) 1994-06-23
WO1994013805A1 (en) 1994-06-23
ATE214734T1 (de) 2002-04-15
GB9415880D0 (en) 1994-09-28
GB2278357A (en) 1994-11-30
PT628077E (pt) 2002-07-31
AU675268B2 (en) 1997-01-30
DE69331735D1 (de) 2002-04-25
GB2278357B (en) 1997-03-05
JPH07504334A (ja) 1995-05-18
AU5656894A (en) 1994-07-04
EP0628077B1 (en) 2002-03-20

Similar Documents

Publication Publication Date Title
DK0771216T3 (da) Fremgangsmåder og præparater til specifik koagulering af tumorvaskulatur
ATE177754T1 (de) Fragmente von prion proteinen.
DK0862633T3 (da) VP-antigen af JC-virus
CR8231A (es) Anticuerpos rg1 y uso de los mismos
ES2139607T3 (es) Anticuerpos monoclonales contra las proteinas e2/ns1 supuestas vhc y procedimientos de utilizacion de estos anticuerpos.
ES2054688T3 (es) Moleculas hibridas recombinantes de inmunoglobulina y su uso.
DE69419721D1 (de) Rekombinante anti-vla4 antikörpermoleküle
EP0914155A4 (en) PROSTATE SPECIFIC MEMBRANE ANTIGEN MONOCLONAL ANTIBODIES
DK0922102T3 (da) Receptor-agonister af hepatocyt-vækstfaktor og anvendelser deraf
ATE248192T1 (de) HUMANISIERTE ANTIKÖRPER DIE AN DAS GLEICHE ANTIGEN WIE ANTIKÖRPER NR-LU-13 BINDEN UND DEREN VERWENDUNG IN ßPRETARGETINGß VERFAHREN
DE69942742D1 (de) Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebs
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
BG101024A (bg) Моноклонално антитяло срещу сd44v6
DE69128543D1 (de) Monoklonale antikörper der maus
DE69128273D1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
DK317787A (da) Haarclip og fremgangsmaade til dennes betjening
PT628077E (pt) Anticorpos humanizados direccionados contra o antigenio de a33
DK0727436T3 (da) Monoklonale antistoffer (MAK) mod tumorassocierede antigener, deres fremstilling og anvendelse
AR115257A1 (es) Anticuerpos de fijación a bcma y sus usos
SE8700467L (sv) Monoklonala humanantikroppberedningar som er korsprotektiva
NO965395L (no) Humane, monoklonale antistoffer som er spesifikke mot cellecyklus-uavhengig gliom-overflateantigen
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
NO973875D0 (no) Fremgangsmåte for simulering av en immunrespons
ES2187796T3 (es) Reactivo de peptidos que permiten la deteccion de citomegalovirus (cmv) humano.
DE69504959D1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 628077

Country of ref document: ES